Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Oral minoxidil 5 mg daily increases hair growth safely in men with hair loss, with minor side effects.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Low-dose oral minoxidil for hair loss can cause mild excessive hair growth, usually appearing within the first 3 months, but it can be managed by adjusting the dose or removing the unwanted hair, with most people not needing to stop the treatment.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Menopause affects hair and skin; more research needed for treatment.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

New treatments for PCOS focus on managing symptoms and improving fertility.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.